Toggle navigation
Home
About Us
About Us
Leadership Team
Board of Directors
Programs
Our Programs
Pipeline
Uveitis
DME
Science
Investors
Patients
Careers
Our Careers
Opportunities
Benefits
Contact
Toggle navigation
Home
About Us
About Us
Leadership Team
Board of Directors
Programs
Our Programs
Pipeline
Uveitis
DME
Science
Investors
Patients
Careers
Our Careers
Opportunities
Benefits
Contact
Hope
 speaks
VIDEO
The suprachoroidal space
Drugs precisely delivered by suprachoroidal injection with access to the choroid and the retina where the diseases present. 
ANIMATION
Drugs will be most effective if they can be delivered directly to the part of the eye that requires treatment, such as the choroid and retina”
Henry Edelhauser
We 
heard
 you.
Eye diseases such as uveitis and diabetic macular edema present in the choroid and retina. Through the ingenious efforts of our research and development team, we have developed a unique and elegant way to access the choroid and retina through the suprachoroidal space to treat these diseases.
PIPELINE
Clinical Program Objectives
Rapid vision gains 
 Sustained vision improvement 
 Consistent patient response 
 Improved benefits to risk ratio
CLS-is administered by suprachoroidal injection.
Not available for clinical use. Not approved by the or other regulatory bodies.
Boundless. Hope.
Join our team at 
Learn more about career opportunities and benefits at Biomedical.
CAREERS
HOME
US
PROGRAMS
INVESTORS
PATIENTS
CAREERS
CONTACT
PRIVACY
Powered by InnovasiumToggle navigation
Home
About Us
About Us
Leadership Team
Board of Directors
Programs
Our Programs
Pipeline
Uveitis
DME
Science
Investors
Patients
Careers
Our Careers
Opportunities
Benefits
Contact
Toggle navigation
Home
About Us
About Us
Leadership Team
Board of Directors
Programs
Our Programs
Pipeline
Uveitis
DME
Science
Investors
Patients
Careers
Our Careers
Opportunities
Benefits
Contact
We see a world without blindness.
The pursuit of transformative, elegant, precise solutions to restore and preserve vision.
Our core values of leadership, achievement, teamwork, integrity, and communication ground us in our pursuit.
Our leadership team
Daniel White
President and CEO
Thomas Ciulla, M.D., MBA
Chief Medical Officer
Charles Deignan
Chief Financial Officer
Brion Raymond
Chief Commercial Officer
Leslie Zacks
General Counsel and Chief Compliance Officer
Our vice presidents
Rafael Andino
Vice President, Engineering & Manufacturing
Carol Hoang, PharmD, MBA
Vice President, Medical Affairs
Edward Lee, Ph.D.
Vice President, CMC
Thomas Crawford
Vice President, Supply Chain
Viral Kansara, Ph.D.
Vice President, Discovery
Rick McElheny
Vice President, Corporate Development
Colette Hall, MD
Vice President, Safety
Jennifer Kissner, Ph.D.
Vice President, Clinical Development
Lester Rodriguez
Vice President, Quality
Our board of 
directors
William Humphries
Chairperson, Executive Vice President of Ortho Dermatologic
Richard Croarkin
Board Member
Jeffrey Edwards
Board Member
George Lasezkay, Pharm.D., J.D.
Board Member
Christy Shaffer, Ph.D.
Board Member, Venture Partner and Managing Director of Hatteras Discovery
Clay Thorp
Board Member, General Partner with Hatteras Venture Partners 
Daniel White
Board Member
Join our team at 
Learn more about career opportunities and benefits at Biomedical.
CAREERS
HOME
US
PROGRAMS
INVESTORS
PATIENTS
CAREERS
CONTACT
PRIVACY
Powered by Innovasium